Photo by Robert Hood / Fred Hutch News Services
On November 1, Fred Hutchinson Cancer Research Center announced the official opening of a first-of-its-kind clinic dedicated to providing innovative immunotherapies for cancer patients in clinical trials. The Bezos Family Immunotherapy Clinic, named in recognition of a family that has been deeply committed to the Hutch and its work to advance immunotherapy, will allow researchers to conduct twice as many immunotherapy trials in the next year in pursuit of speeding cures for cancer.
Dr. David Maloney, Fred Hutch’s first medical director of Cellular Immunotherapy, is medical director of the Bezos Family Immunotherapy Clinic. Maloney will lead the clinic’s physicians and oversee the research and patient care in the clinic.
Patients will be able to receive the Hutch’s novel immunotherapies for cancer at roughly double the capacity that existed before the 9,222-square-foot clinic opened. More importantly, intensive monitoring in this groundbreaking facility will enable researchers to better understand why some patients respond, where others do not, and to achieve the goal of developing the best curative approach to treatment for each individual patient.